Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
The latest announcement is out from TSURUHA Holdings ( (JP:3391) ).
TSURUHA Holdings reported consolidated net sales of ¥833.3 billion and net income attributable to owners of the parent of ¥27.0 billion for the nine months ended November 30, 2025, its first disclosed nine-month figures under the new February fiscal year-end and after a five-for-one stock split. Total assets rose to ¥664.5 billion and equity to ¥298.9 billion, though the equity ratio edged down to 45.0%, while the company revised its dividend forecast to reflect the stock split and now projects full-year fiscal 2025/26 net sales of ¥1.453 trillion and net income of ¥39.5 billion, signaling confidence in continued growth amid structural and accounting changes that may affect how investors assess per-share metrics and capital efficiency going forward.
The most recent analyst rating on (JP:3391) stock is a Hold with a Yen2700.00 price target. To see the full list of analyst forecasts on TSURUHA Holdings stock, see the JP:3391 Stock Forecast page.
More about TSURUHA Holdings
TSURUHA Holdings Inc. is a Japan-based operator of drugstore chains, primarily engaged in the retail sale of pharmaceuticals, cosmetics, daily necessities and related products. Listed on the Tokyo Stock Exchange Prime Market, the company targets consumers across Japan through its extensive store network and positions itself as a major player in the domestic drugstore and healthcare retail sector.
Average Trading Volume: 2,010,674
Technical Sentiment Signal: Buy
Current Market Cap: Yen1292.8B
Learn more about 3391 stock on TipRanks’ Stock Analysis page.